Role of cholecystokinin receptor in hepatocellular cancer

Information

  • Research Project
  • 10301859
  • ApplicationId
    10301859
  • Core Project Number
    K01CA255572
  • Full Project Number
    1K01CA255572-01A1
  • Serial Number
    255572
  • FOA Number
    PAR-18-364
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 2 years ago
  • Project End Date
    8/31/2026 - 2 years from now
  • Program Officer Name
    TILAHUN, MULUALEM ENYEW
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    8/30/2021 - 2 years ago
Organizations

Role of cholecystokinin receptor in hepatocellular cancer

Project Summary/ Abstract Background: The cholecystokinin (CCK) receptor is a G-protein coupled receptor that regulates physiologic gastrointestinal digestive functions and growth of the gastrointestinal tract. CCK receptors become overexpressed in gastrointestinal cancers where receptor activation by the ligands, CCK on or gastrin, stimulate cancer growth and metastases. CCK receptors have also been described as fibroblasts. When activated, these cells produce collagen-associated proteins that lead to fibrosis associated with malignancies and are thought to impede the penetration of therapeutic agents. Innovation: We recently showed that a diet high in saturated fat induces the expression of hepatic CCK- B receptors in a murine model of nonalcoholic steatohepatitis. The CCK receptor antagonist, proglumide, reversed inflammation, fibrosis, and steatosis prevented the development of hepatocellular carcinoma in the murine NASH model. Long-term objectives: In this proposal, I plan to investigate the mechanisms of how CCK receptors mediate hepatic inflammation and fibrosis and the role of CCK receptors in hepatocellular cancer. Research Aims: In vitro studies will be performed to analyze the potential of cross-talk between CCK receptors and chemokine receptors. The role of CCK receptors in regulating hepatic fibrosis in stellate cells will be carried out in vitro using CRISPR technology to selectively knockout cancer cell CCK receptors and in vivo with transgenic mice engineered to be null in the CCK-B receptor. Lastly, we will examine the novel idea of whether liver injury and NASH induce proliferation of hepatic stem cells that express CCK-B receptors and these stem cells are responsible for HCC. Candidate's Goals: Are to understand the pathophysiology of CCK receptors in liver cancer development and progression. This proposal will be completed under the guidance of an experienced mentor team that includes accomplished tumor biologists, immunologists, and hepatology cancer researchers. To accomplish these goals, the candidate will work with her mentors and constantly review research objectives for publication to address candidate?s publication record and the Professional Development Office to follow a career development plan by incorporating diverse methodologies for advancement, which includes manuscript preparation, project management adhering to timelines, effectively managing a budget, attending and presenting at national conferences and departmental seminars, mentoring graduate and undergraduate students, and preparing application materials.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    K01
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
    150897
  • Indirect Cost Amount
    12072
  • Total Cost
    162969
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    398
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NCI:162969\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    NCI
  • Study Section Name
    Subcommittee I - Transistion to Independence
  • Organization Name
    GEORGETOWN UNIVERSITY
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    049515844
  • Organization City
    WASHINGTON
  • Organization State
    DC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    200570001
  • Organization District
    UNITED STATES